ArticleClinical rheumatology2026
Gout flares, serum urate and seasonality: a descriptive cohort study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Elevated calculated serum osmolality during acute gout attacks is associated with pain severity and systemic ınflammation: a retrospective paired observational study.Rheumatology international · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo investigate the relationship between serum urate levels and gout flares and how these vary at different times of the year.
methodsA cohort of people with incident gout was established using a large UK primary care database (Clinical Practice Research Database). Clinician-recorded gout flares and serum urate (SU) measurements were identified and described using joinpoint linear regression modelling. The relationship between SU level, flare frequency, month of the year and mean monthly temperatures was explored and correlations tested using Pearson correlation coefficients.
results249,157 individuals (mean follow-up 6.7 years) experienced 417,101 flares and had 341,457 SU measurements (mean SU 437 µmol/L, standard deviation (SD) 106 µmol/L). SU levels peaked the day before a flare (487 µmol/L). Mean SU in the year preceding a flare was 474 µmol/L compared with 432 µmol/L in the year post-flare. SU levels did not near pre-flare levels in the year following a flare. Flares were most frequent, and SU was highest, in the summer months (June to August). The correlation co-efficient between flares and months of the year was 0.94, whereas the correlation with temperature was less strong (0.70).
conclusionsSU measurement in the year following a gout flare is not indicative of the peak (pre-flare) SU levels that an individual may have experienced. Clinicians should consider this when considering SU measurements in the diagnosis of gout. Patients may find it helpful to be informed of the seasonality of gout flares and advised to take extra caution to reduce the risk of flares during summer months. Keypoints • Serum urate (SU) levels drop precipitously during gout flares and remain low for several months. • Correlations exist between flare rate and summer months, and with seasonal variation in SU levels. • Clinicians should be aware of how gout flares affect SU when interpreting SU levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.